Leveraging Artificial Intelligence to Prevent Vision Loss From Diabetes

Recruiting N/A Interventional Study
Diabetic Retinopathy Diabetes Mellitus
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
22 and older
Sex
Any
Study type
Interventional
Purpose
Health Services Research
Participants needed
6,900 (estimated)
Sponsor
University of Wisconsin, Madison · Other
Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
This pragmatic clinical trial is being conducted to test the effectiveness of AI-BRIDGE (Artificial Intelligence-Based point of caRe, Incorporating Diagnosis, SchedulinG, and Education), in improving screening and follow-up eye care compared to usual-care among patients with diabetes across 8 primary care clinics. AI-BRIDGE is an implementation program which includes an autonomous AI-based protoco…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Clinics Inclusion Criteria: * Clinic must be from a health system with at least two clinics that meet eligibility criteria and will agree to join. * Number of unique patients with diabetes should be \>550 over any continuous 15-month period prior to the clinic providing a letter of support to parti…
Contacts

Mozhdeh Bahrainian

608-262-9955

bahrainian@wisc.edu

CONTACT

Roomasa Channa

rchanna@wisc.edu

CONTACT